Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehiko Sakai

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Breast Cancer Research and Treatment|September 23, 2018
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS studyHiroji Iwata, Norikazu Masuda, Yutaka Yamamoto, et al.
Breast Cancer (Tokyo, Japan)|May 23, 2022
Characteristics, treatment trends, and long-term outcomes of Japanese patients with pregnancy-associated breast cancer (PABC)Akemi Kataoka, Takayuki Ueno, Hideko Yamauchi, et al.
Breast Cancer (Tokyo, Japan)|August 1, 2025
A retrospective multi-center cohort study investigating safety of sentinel lymph node biopsy for axillary staging in clinical T3-4c breast cancerSayaka Kuba, Yasuaki Sagara, Hiroshi Yano, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Breast Cancer Research and Treatment|September 23, 2018
Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS studyHiroji Iwata, Norikazu Masuda, Yutaka Yamamoto, et al.
Breast Cancer (Tokyo, Japan)|May 23, 2022
Characteristics, treatment trends, and long-term outcomes of Japanese patients with pregnancy-associated breast cancer (PABC)Akemi Kataoka, Takayuki Ueno, Hideko Yamauchi, et al.
Breast Cancer (Tokyo, Japan)|August 1, 2025
A retrospective multi-center cohort study investigating safety of sentinel lymph node biopsy for axillary staging in clinical T3-4c breast cancerSayaka Kuba, Yasuaki Sagara, Hiroshi Yano, et al.
Pageof 6